News About: Pharm. Industry
Japanese pharmaceutical companies fighting well in outpatient prescription market
Japanese pharmaceutical companies have had upturns in the domestic outpatient prescription market. In particular, growths of pharmaceutical companies that have specialization strategies have stood out.
According to t...
‘1 Strong and 2 Medium’ positions in Celebrex generic market
In the market of ‘Celebrex(generic name: celecoxib), a selective COX-2 inhibitor anti-inflammatory drug, which was recognized as the most competitive market due to approximately 100 generic products launched, Chong Ku...
Eisai’s exclusive promotion for ‘Pariet’
Eisai is going to start the exclusive promotion for its representative PPI drug, ‘Pariet(rabeprazole).’
According to the industry concerned on the 22nd, Janssen and Eisai have recently terminated the joint sales cont...
Hanmi Pharm’s ‘Amosartan,’ the hottest seller among improved drugsAmong improved drugs developed by pharmaceutical companies, the hottest seller was observed to be ‘Amosartan,’ a Hanmi Pharm’s hypertension treatment.
‘Amosartan,’ which approv...
|
Real sales price of drugs unveiled today… what are reduction benefits?
The result of the ceiling price adjustment on pharmaceutical products, which reflects opinions of the pharmaceutical industry, can be confirmed today(20th).
The Health Insurance Review & Assessment Service(Chairman M...
Entry of ‘Two-strong System’ for Cialis generics
Generics of ‘Cialis,’ an erectile dysfunction treatment, have been sorted out into two strong products.
According to the interested industry, 150 products have been poured out and competed after the patent expiration...
“Belviq has a high prescription rate, which was secured by its safety”“In fact, Belviq has been prescribed a lot. A bit pricey, but its safety seems to secure the amount of prescriptions.”
After liquidation of ‘sibutramine,’ a obesity treatment, ...
|
Pharmaceutical companies’ desire to have drug price reflecting value of new drugs
The academic world and industry have agreed that the pharmaceutical industry requires an environment which creates extension of expenses of domestic pharmaceutical companies for the global expansion of the pharmaceuti...
Hanmi Pharm wins the final ‘Viagra’ design trial reversing the second oneReversing its second trial, Hanmi Pharm won the ‘Viagra’ design lawsuit against Pfizer Korea.
On the 15th, the Supreme Court announced dismissal of the Pfizer’s claim, an injun...
|
Sudden resignation of President Choon-yup Lee at Takeda Pharmaceuticals KoreaIt was observed President Choon-yup Lee who launched Takeda Pharmaceuticals Korea has resigned the position in the fifth year of his service last 14th.
Born in 1959, President ...
|
